Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

NCT00141726 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Lung Injury, Acute
Respiratory Distress Syndrome, Adult
Bronchiolitis Obliterans

Interventions

DRUG: Etanercept

Sponsor

University of Michigan Rogel Cancer Center